Dexcom Inc.

DXCM·NASDAQ·$72.01Share Price as of 11/2·$28BMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/29/26 10-QQ2 ended 06/30/2607/30/26 10-QQ1 ended 03/31/2604/30/26 10-KFY 202502/12/26 10-QQ3 ended 09/30/2510/30/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report09/14/26 8-KCurrent report09/10/26 8-KCurrent report07/30/26 8-KCurrent report05/28/26

Prospectuses and Registrations

S-8Registration of securities for employees05/09/25 S-3ASRAutomatic shelf registration02/18/25 424B5Prospectus supplement11/22/21 S-3ASRAutomatic shelf registration11/22/21 S-8 POSPost-effective amendment (S-8)02/10/21

Proxies

DEF 14ADefinitive proxy04/15/26 DEFA14AAdditional proxy materials04/15/26 DEFA14AAdditional proxy materials05/02/25 DEF 14ADefinitive proxy03/27/25 DEFA14AAdditional proxy materials03/27/25

Ownership

Form 4Insider transaction10/28/26 144Proposed sale of securities10/27/26 Form 4Insider transaction10/19/26 144Proposed sale of securities10/15/26 Form 4Insider transaction09/30/26

Other

SDConflict Minerals disclosure05/28/26 ARSAnnual report to shareholders04/15/26 SDConflict Minerals disclosure05/29/25 ARSAnnual report to shareholders03/27/25 SDConflict Minerals disclosure05/29/24